安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Allogeneic T-cell Immunotherapy Company - Atara Biotherapeutics
Atara is an allogeneic T-cell immunotherapy company We're harnessing the natural biology of T cells—our body’s most effective weapon in fighting disease—to develop transformative therapies for patients with cancer and autoimmune conditions
- T-Cell Immunotherapy Technology Platform - Atara Biotherapeutics
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases
- T-cell immunotherapies for cancer, autoimmune . . . - Atara Biotherapeutics
Atara Biotherapeutics’s robust, late-stage pipeline features a host of potentially transformative T-cell immunotherapies for cancer, autoimmune and viral diseases
- Atara Biotherapeutics (ATRA)
Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory
- Careers - Atara Biotherapeutics - Atara Biotherapeutics
When people ask about your career with Atara, your answer will be compelling Because we’re a pioneer in T-cell immunotherapy, leveraging our novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases, including cancer and autoimmune diseases
- Technology - Atara Biotherapeutics
As a leading allogeneic T-cell immunotherapy company, Atara is pioneering the development of transformative therapies for patients with serious diseases by leveraging our novel allogeneic Epstein Barr virus (EBV) T-cell platform
- Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics . . .
Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory
- Atara Biotherapeutics Provides Regulatory Updates on EBVALLO . . .
Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory
|
|
|